Skip to Main Content

Paper Details

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.
J Clin Med
13
2020
16/18, 16/18 E6/E7 gene, BVAC, Cervical Cancer, E6, E7, HPV, HPV 16-positive or 18-positive recurrent cervical carcinoma, HPV 16/18 E6/E7-specific T cells, Human, Human Papillomavirus Type 16- or 18-Positive Recurrent, Patients, alpha-galactosyl ceramide, cervical cancer, fever, human papillomavirus, myalgia, natural, natural killer T cells, natural killer cells, patient, patients, platinum, platinum-resistant recurrent cervical cancer, recombinant, tumor
Author NameAffiliation
Jeong-Won LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Yong-Man KimUniversity of Ulsan College of Medicine, Asan Medical Center
Chang-Yuil KangSeoul National University
  • 1 - 3

Datasets

Release 1.2